Levetiracetam: An improvement of attention and of oral fluency in patients with partial epilepsy

Epilepsy Research

Volumn 68, Issue 3, 2006, Pages 181-188

  Piazzini, Ada ^a   Chifari, Rosanna ^a   Canevini, Maria Paola ^a   Turner, Katherine ^a   Fontana, Stefano Paveri ^a   Canger, Raffaele ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cognitive function; Epilepsy; Levetiracetam

Indexed keywords

ETIRACETAM;

ADD ON THERAPY; ADULT; ANTICONVULSANT THERAPY; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOCAL EPILEPSY; HUMAN; LANGUAGE ABILITY; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VERBAL BEHAVIOR;

ADULT; ANTICONVULSANTS; ATTENTION; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PIRACETAM; SPEECH DISORDERS; TREATMENT OUTCOME;

EID: 33644520264     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2005.10.006     Document Type: Article

References (45)

1. A.P. Aldenkamp, A.V. Wieringen, W.C.J. Alpherts, B.W. van Emde, H.A. Haverkort, J. de Vries, and H. Meinardi Double-blind placebo controlled neuropsychological and neurophysiological investigations with Oxiracetam (CGP 21690E) in memory impaired patients with epilepsy Neuropsychobiology 24 1990 90 101
2. A.P. Aldenkamp, M. De Krom, and R. Reijs Newer antiepileptic drugs and cognitive issues Epilepsia 44 2003 1 12
3. E. Ben-Menachen, P. Edrich, B. Van Vleymen, J.W. Sander, and B. Schmidt Evidence for substained efficacy of levetiracetam as add-on epilepsy therapy Epilepsy Res. 53 2003 57 64
4. A.L. Benton, and K.S. de Hamsher Multilingual Aphasia Examination 1989 AJA Associates Iowa City, Iowa
5. G.K. Bergey, G.L. Krauss, and R.S. Lesser Tolerability of levetiracetam with high-and low-dose initiation Neurology 56 2001 335 336
6. S. Birnstiel, E. Wulfert, and S.G. Beck Levetiracetam effects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission Arch. Pharm. Res. 356 5 1997 611 618
7. L. Brunbech, and A. Sabers Effect of antiepileptic drugs on cognitive function in individuals with epilepsy Drugs 62 4 2002 593 604
8. M.P. Canevini, R. Chifari, and A. Piazzini Improvement of a patient with stuttering on levetiracetam Neurology 59 8 2002 1228 1230
9. E. Capitani, M. Laiacona, and E. Ciceri A re-analysis of block tapping long term memory according to the short term memory Ital. J. Neurol. Sci. 12 1991 461 466
10. J.J. Cereghino, V. Biton, B. Abou-Khalil, F. Dreifuss, L.J. Gauer, and I.E. Leppik Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial Neurology 55 2000 236 242
11. J.O. Coq, and C. Xerri Acute reorganization of the forepaw representation in the rat SI cortex after focal cortical injury: neuroprotective effects of piracetam treatment Eur. J. Neurosci. 11 1999 2597 2608
12. J.A. Cramer, C. Arrigo, G. Van Hammée, L.J. Gauer, and J.J. Cereghino Effect of levetiracetam on epilepsy-related quality of life. N.132 Study Group Epilepsia 41 7 2000 868 874
13. J.A. Cramer, I.E. Leppik, K. De Rue, P. Edrich, and G. Krämer Tolerability of levetiracetam in elderly patients with CNS disorders Epilepsy Res. 56 2003 135 145
14. J.A. Cramer, K. De Rue, O. Devinsky, P. Edrich, and M.R. Trimble A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorder, or an anxiety disorder during clinical trials Epilepsy Behav. 4 2003 124 132
15. E. De Renzi, and L.A. Vignolo The Token test: a sensitive test to detect receptive disturbances in aphasia Brain 86 1962 665 678
16. M.E. Eson, J.K. Yen, and R.S. Bourke Assessment of recovery from serious head injury J. Neurol. Neurosurg. Psychiat. 41 1978 1036 1042
17. Flicker, L., Grimley, E.J., 2000. Piracetam for dementia or cognitive impairment (Cochrane Review). Cochrane Database Syst. Rev. The Cochrane Collaboration, Oxford.
18. J. French, P. Edrich, and J.A. Cramer A systematic review of the safety profile of levetiracetam: a new antiepileptic drug Epilepsy Res. 47 2001 77 90
19. P. Genton, and B. Van Vleymen Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles Epileptic Disord. 2 2 2000 99 105
20. A.R. Giovagnoli, and A. Piazzini L'approccio neuropsicologico nei pazienti con Epilessia parziale, quale i metodi piu' appropriati? Boll. Lega It. Epil. 89 1994 7 10
21. A.R. Giovagnoli, M. Del Pesce, S. Mascheroni, M. Simoncelli, M. Laiacona, and E. Capitani Trail Making Test: normative values from 287 adult controls Ital. J. Neurol. Sci. 17 1996 305 309
22. C.E. Giurgea, M.G. Greindl, and S. Preat Nootropic drugs and aging Acta Psychiatr. Belg. 83 1983 349 358
23. O.M. Glozman, I.S. Morozov, and L.A. Zhmurenko Synthesis and anticonvulsant activity of 4-phenyl-pyrrolidone-2-acetic acid-1-amides Russ. Pharmacol. Toxicol. 44 2 1981 22 29
24. R. Grant, and S.D. Shorvon Efficacy and tolerability of 10 000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy Epilepsy Res. 42 2000 89 95
25. C. Harden Safety profile of levetiracetam Epilepsia 42 2001 36 39
26. F.J. Hock Drug influences on learning and memory in aged animals and humans Neuropsychobiology 17 1987 145 160
27. J. Kesser, A. Thiel, and H. Karbe Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patient Stroke 31 2000 2112
28. I.E. Leppik, V. Biton, J.W.A. Sander, and H.G. Wieser Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials Epilepsia 44 2 2003 1585 1587
29. M.D. Lezak Neuropsychological Assessment 1995 Oxford University Press New York
30. C. Mandadori Pharmacological modulation of memory: trends and problems Acta Neurol. Scand. 64 89 1981 129 140
31. B.S. Meldrum Gamma-aminobutyric acid and the search for new anticonvulsant drugs Lancet 2 1978 304 306
32. W.E. Müller, H. Hartmann, and S. Koch Neurotransmission in aging: therapeutic aspects N. Racagni N. Brunello S.Z. Langer Recent Advances in the Treatment of Neurodegenerative Disorders and Cognitive Dysfunction 1994 Karger Basel 166 173
33. L.G. Neyens, W.C. Alpherts, and A.P. Aldenkamp Cognitive effects of a new pyrrolidine derivate - levetiracetam - in patients with epilepsy Prog. Neuropsychopharmacol. Biol. Psychiatry 19 1995 411 419
34. G. Novelli, C. Papagno, E. Capitani, M. Laiacona, S.F. Cappa, and G. Vallar Tre test clinici di memoria verbale a lungo termine Arch. Psychol. Neurol. Psychiatr. 47 1986 278 296
35. G. Novelli, C. Papagno, E. Capitani, M. Laiacona, S.F. Cappa, and G. Vallar Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali Arch. Psychol. Neurol. Psychiatr. 47 1986 477 506
36. A. Orsini, D. Grossi, E. Capitani, M. Laiacona, C. Papagno, and G. Vallar Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children Ital. J. Neurol. Sci. 8 1987 539 548
37. P.N. Patsalos Pharmacokinetic profile of levetiracetam: toward ideal characteristics Phamarcol. Ther. 85 2 2000 77 85
38. A. Piazzini, R. Chifari, K. Turner, M.P. Canevini, and R. Canger Levetiracetam: a cognitive study Epilepsia 43 8 2002 169 170
39. A. Rey Reattivo della Figura Complessa 1968 Organizzazioni Seciali Firenze
40. B. Saletu, and J. Grünberger Memory dysfunction and vigilance; neurophysiological and psychopharmacological aspects Ann. NY Acad. Sci. 444 1985 406 427
41. U. Schindler Pre-clinical evaluation of cognition enhancing drugs Prog. Neuropsychopharmacol. Biol. Psychiatry 13 1989 S99 S115
42. S.D. Shorvon, A. Löventhal, D. Janz, E. Bielen, and P. Loiseau Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory seizures Epilepsia 41 2000 1179 1186
43. D.H.K. Shum, K.A. McFarland, and J.D. Bain Construct validity of 8 tests of attention: comparison of normal and closed head injured samples Clin. Neuropsychol. 4 1990 151 162
44. H. Spinnler, and G. Tognoni Standardizzazione e taratura italiana di test neuropsicologici Ital. J. Neurol. Sci. 6 1987 1 120
45. J.R. White, T.S. Walczak, I.E. Leppik, J. Rarick, T. Tran, T.E. Beniak, D.J. Matchinsky, and R.J. Gumnit Discontinuation of levetiracetam because of behavioural side effects Neurology 61 2003 1218 1221